<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25187" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Miscarriage (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dugas</surname>
            <given-names>Carla</given-names>
          </name>
          <aff>Inspira Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Slane</surname>
            <given-names>Valori H.</given-names>
          </name>
          <aff>Kendall Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Carla Dugas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Valori Slane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>6</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25187.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Spontaneous abortion or miscarriage is defined as the loss of pregnancy less than 20 weeks gestation. The American College of Obstetricians and Gynecologists (ACOG) estimates it is the most common form of pregnancy loss. It is estimated that as many as&#x000a0;26% of all pregnancies end in miscarriage and up to 10% of clinically recognized pregnancies.<xref ref-type="bibr" rid="article-25187.r1">[1]</xref><xref ref-type="bibr" rid="article-25187.r2">[2]</xref>&#x000a0;<xref ref-type="bibr" rid="article-25187.r3">[3]</xref>&#x000a0;Moreover, 80% of early pregnancy loss occurs in the first trimester.&#x000a0;<xref ref-type="bibr" rid="article-25187.r1">[1]</xref><xref ref-type="bibr" rid="article-25187.r2">[2]</xref>&#x000a0;The risk of miscarriage decreases after 12 weeks gestation.</p>
        <p>The terms miscarriage and abortion are used interchangeably. The term abortion refers to a termination of a pregnancy either natural or induced. There are several terms&#x000a0;that describe different states of pregnancy loss.&#x000a0;These terms&#x000a0;include threatened, inevitable, complete, and missed abortion.&#x000a0;Threatened abortion is the presence of vaginal bleeding in early pregnancy but on pelvic exam, the cervical os is closed and the transvaginal ultrasound shows a viable fetus. <xref ref-type="bibr" rid="article-25187.r3">[3]</xref>&#x000a0;Inevitable abortion is when there is vaginal bleeding but on the pelvic&#x000a0;exam, the cervical os is open meaning that the fetus or products of conception are expected to pass through the cervix in the near future. On transvaginal ultrasound, there can be either be a viable fetus or not. <xref ref-type="bibr" rid="article-25187.r4">[4]</xref>&#x000a0;Complete abortion is when there is initially vaginal bleeding and passing of products of conception through the cervix. On transvaginal&#x000a0;ultrasound, there would be no remaining products of conception in the uterus. A missed abortion refers to when there was vaginal bleeding and perhaps some passage of tissue or products of conception. On pelvic exam, the cervical os would be closed. On transvaginal ultrasound, there would be retained products of conception and there would not be a viable fetus.&#x000a0;</p>
      </sec>
      <sec id="article-25187.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common cause of spontaneous pregnancy loss in the first trimester is chromosomal abnormalities. In most cases, it is too early to determine the exact cause of the abnormality. The risk of early pregnancy loss decreases with increasing gestational age and is relatively low after 15-weeks gestation in a genetically normal fetus.<xref ref-type="bibr" rid="article-25187.r5">[5]</xref></p>
      </sec>
      <sec id="article-25187.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The risk of miscarriage is multivariate, and while some maternal risk factors tend to be more important than others, there is no one predictor of future pregnancy loss. Maternal age is an important predictor of the risk of miscarriage. In women ages, 20 to 30 risk of miscarriage less than 20 weeks gestation is 8.9%. This increases to 74.7% for women over 40 years<xref ref-type="bibr" rid="article-25187.r6">[6]</xref>&#x000a0;Another important predictor in the risk of early pregnancy loss is prior obstetrical history. The risk of miscarriage in a future pregnancy is approximately 20% after 1 miscarriage, 28% after 2 consecutive miscarriages, and 43% after 3 or more consecutive miscarriages.<xref ref-type="bibr" rid="article-25187.r7">[7]</xref></p>
        <p>Maternal comorbidities such as thrombophilia, antiphospholipid antibody syndrome, extremes of maternal weight, and hypertension also increase the risk of miscarriage. Additional maternal risk factors have been identified such as cigarette smoking, large amounts of caffeine use, trauma, and malnutrition.&#x000a0;<xref ref-type="bibr" rid="article-25187.r3">[3]</xref></p>
      </sec>
      <sec id="article-25187.s4" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Signs of early pregnancy loss vary and can often be confused with complications or symptoms of a normal intrauterine pregnancy as well as ectopic pregnancy. Most commonly patients present with pelvic and abdominal cramping with or without vaginal bleeding and a positive pregnancy test or missed or abnormal menstrual cycle.</p>
      </sec>
      <sec id="article-25187.s5" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The most important determination when evaluating a pregnant patient with symptoms of miscarriage is whether or not this is a true loss, an ectopic pregnancy, molar pregnancy, or a viable pregnancy with complications.&#x000a0;</p>
        <p>Ultrasound is the gold standard for examining intrauterine contents and viability. This paired with a quantitative human chorionic gonadotropin (hCG) hormone level can help determine viability. hCG levels should double in 48 hours on serial exams.<xref ref-type="bibr" rid="article-25187.r8">[8]</xref></p>
        <p>At hCG levels between 1000 to 2000, it has been determined that transvaginal ultrasound (TVUS) is the most sensitive study for identifying intrauterine contents such as a gestational sac with or without a fetus or embryo. There have been multiple studies that reveal a correlation between hCG levels and the stage of embryonic development seen on ultrasound. For instance, at a range of serum hCG between 800 to 1500 UI/I, a 1 to 3 mm gestational sac should be visible on TVUS. Furthermore, a yolk sac should be detectable within the range hCG level of 4500 to 7500 UI/I; with fetal heart motion visible at a range of 8650 to 12,200 U/I.<xref ref-type="bibr" rid="article-25187.r9">[9]</xref></p>
        <p>Cardiac activity should be identifiable at a crown-rump length of 5 mm or greater.<xref ref-type="bibr" rid="article-25187.r8">[8]</xref></p>
        <p>Findings suggestive of but not definitive of early pregnancy loss on transvaginal ultrasound are a crown-rump length (CRL) of 7 mm or greater without fetal cardiac activity or an empty gestational sac with no embryo of 16 to 24 mm or greater in diameter.&#x000a0;<xref ref-type="bibr" rid="article-25187.r10">[10]</xref></p>
        <p>The American College of Obstetricians and Gynecologists (ACOG), therefore, recommends serial hCG levels as well as serial ultrasounds to determine viability.<xref ref-type="bibr" rid="article-25187.r11">[11]</xref></p>
      </sec>
      <sec id="article-25187.s6" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment options include expectant management, medication, or surgical interventions.</p>
        <p>Decisions are often made jointly with the patient and the obstetrician as to&#x000a0;which path to choose. As long as patients are hemodynamically stable and do not require emergency&#x000a0;surgery, there is no difference in long-term outcomes when comparing these treatment options.</p>
        <p>Expectant management is typically limited to those miscarrying in the first trimester due to lack of studies beyond that timeframe and presumed increased risk of bleeding complications beyond that. Approximately 80% of women achieve complete passage of intrauterine contents within 8 weeks.<xref ref-type="bibr" rid="article-25187.r12">[12]</xref></p>
        <p>Medical management can be used in the absence of contraindications, including severe anemia, bleeding disorders, or infection.<xref ref-type="bibr" rid="article-25187.r11">[11]</xref>&#x000a0;Misoprostol, a prostaglandin analog, is given in 1 or 2 doses to achieve induced passage of intrauterine contents. Misoprostol can be taken in the oral form, sublingual, or as a vaginal suppository. Most women will achieve complete expulsion within 3 days, and very&#x000a0;few need subsequent uterine curettage.</p>
        <p>Surgical evacuation is another option in the treatment of early pregnancy loss and is achieved either with sharp curettage or suction curettage.&#x000a0;Surgical evacuation is preferred in women who present with hemorrhage, hemodynamic instability, or signs of infection because these conditions require urgent treatment.<xref ref-type="bibr" rid="article-25187.r11">[11]</xref>&#x000a0;This is also the preferred method of treatment for women with comorbid conditions such as cardiovascular disease, infection, severe anemia, or bleeding disorders.&#x000a0;</p>
        <p>While success rates for surgical evacuation reach 99%,<xref ref-type="bibr" rid="article-25187.r13">[13]</xref>&#x000a0;the risk of complications among all 3 treatment options remains low and is equivocal in women without comorbid conditions or contraindications to one form or another. Hemorrhage and infection appear to be the 2 most common complications across all three treatment types.</p>
        <p>Another important consideration that must be taken into account when evaluating&#x000a0;pregnant females with complaints consistent with miscarriage is their Rh status. This is important due to the fact that the fetus could differ in Rh type from the mother. &#x000a0;If mother and fetus have different Rh types, this sets up a scenario where the mother could be exposed to a differing Rh from exposure to the fetal blood type. This could cause the mother to produce antibodies against the different Rh to which it was exposed. These antibodies can then cross the placenta and affect the fetus. &#x000a0; This can then present serious consequences to the fetus and cause the fetus to develop a high output cardiac failure state known as hydrops fetalis, which is nearly 100% fatal. &#x000a0;All women who have a blood type that is Rh(D) negative who are diagnosed with early pregnancy loss, and have not been sensitized, should receive Rh(D)-immune globulin 50 micrograms (or 300 micrograms if available) to prevent alloimmunization. Rh(D)-immune globulin should be administered as early as possible, within 72 hours, of diagnosis of miscarriage and immediately following surgical intervention.&#x000a0;</p>
        <p>To date, there exists no proven strategy to prevent early pregnancy loss. Suggestions such as pelvic rest and hormone administration have not been proven. However, some physicians advocate progestin administration early to women who have experienced multiple prior miscarriages. Anticoagulants or aspirin administration has only been proven to be beneficial in women with antiphospholipid antibody syndrome.<xref ref-type="bibr" rid="article-25187.r14">[14]</xref><xref ref-type="bibr" rid="article-25187.r15">[15]</xref></p>
      </sec>
      <sec id="article-25187.s7" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential for early pregnancy loss includes ectopic pregnancy, viable pregnancy with implantation bleeding, molar pregnancy, viable pregnancy with complications. There are also non-uterine causes of bleeding that can be mistaken for miscarriage such as vaginal trauma.</p>
      </sec>
      <sec id="article-25187.s8" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education is important in early pregnancy loss as this can be an emotionally difficult diagnosis. Patient education should focus on maternal health and preparing for future pregnancy. There has been no data to support delaying conception after an early pregnancy loss to prevent subsequent miscarriage or complications.<xref ref-type="bibr" rid="article-25187.r11">[11]</xref>&#x000a0;Although most physicians recommend abstaining from vaginal intercourse for 1 to 2 weeks after the passage of tissues, there is no data to support this recommendation.<xref ref-type="bibr" rid="article-25187.r11">[11]</xref></p>
        <p>Patients should also be provided with education regarding contraception after a miscarriage including the use of an intrauterine device or hormonal contraception as both have been deemed safe for use immediately following an early pregnancy loss.<xref ref-type="bibr" rid="article-25187.r16">[16]</xref></p>
        <p>It is important to provide each Rh(D) negative patient education on alloimmunization and risk of future pregnancy with regards to receiving Rh(D) immune globulin.</p>
        <p>Most importantly, while there are no proven strategies to reduce the risk of subsequent pregnancy loss after a miscarriage, patient education on maternal health is important. Patients should be provided with education on managing blood pressure, extremes of weight, and cigarette smoking cessation.</p>
      </sec>
      <sec id="article-25187.s9" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Miscarriage is the loss of a pregnancy before 20 weeks gestation.</p>
        <p>Before 12 weeks, gestation most pregnancy loss is due to chromosomal abnormalities.</p>
        <p>Maternal health such as high blood pressure, obesity, and cigarette smoking may increase the risk of miscarriage.</p>
        <p>Advanced maternal age has been proven to increase the risk of miscarriage with risks as high as 74% for women over age 40.</p>
        <p>It is important to evaluate using transvaginal ultrasound to determine whether or not a pregnancy is viable.</p>
        <p>For women with no co-morbid conditions, all 3 treatment options (medical, surgical, or expectant management) have been proven equally safe and effective.</p>
      </sec>
      <sec id="article-25187.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Treating patients who experience pregnancy loss requires close coordination between all members of the care team. Follow-up care with an obstetrician needs to be coordinated. &#x000a0;Clear and concise discharge instructions need to be given to the patient. &#x000a0;This experience for the patient can be very emotionally taxing and needs to be handled with extreme compassion and sensitivity. &#x000a0;</p>
      </sec>
      <sec id="article-25187.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25187&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25187">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25187/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25187">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25187.s12">
        <title>References</title>
        <ref id="article-25187.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilcox</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Schlatterer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Canfield</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Nisula</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Incidence of early loss of pregnancy.</article-title>
            <source>N Engl J Med</source>
            <year>1988</year>
            <month>Jul</month>
            <day>28</day>
            <volume>319</volume>
            <issue>4</issue>
            <fpage>189</fpage>
            <page-range>189-94</page-range>
            <pub-id pub-id-type="pmid">3393170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zinaman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Clegg</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Selevan</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Estimates of human fertility and pregnancy loss.</article-title>
            <source>Fertil Steril</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>503</fpage>
            <page-range>503-9</page-range>
            <pub-id pub-id-type="pmid">8774277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanmaz</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>&#x00130;nan</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Beyan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Budak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The effects of threatened abortions on pregnancy outcomes.</article-title>
            <source>Ginekol Pol</source>
            <year>2019</year>
            <volume>90</volume>
            <issue>4</issue>
            <fpage>195</fpage>
            <page-range>195-200</page-range>
            <pub-id pub-id-type="pmid">30901073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birch</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mandalia</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cervical shock: a complication of incomplete abortion.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28710197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyatt</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Owolabi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Age-specific risk of fetal loss observed in a second trimester serum screening population.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>192</volume>
            <issue>1</issue>
            <fpage>240</fpage>
            <page-range>240-6</page-range>
            <pub-id pub-id-type="pmid">15672031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nybo Andersen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wohlfahrt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Christens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Melbye</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Maternal age and fetal loss: population based register linkage study.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Jun</month>
            <day>24</day>
            <volume>320</volume>
            <issue>7251</issue>
            <fpage>1708</fpage>
            <page-range>1708-12</page-range>
            <pub-id pub-id-type="pmid">10864550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Braude</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Trembath</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Influence of past reproductive performance on risk of spontaneous abortion.</article-title>
            <source>BMJ</source>
            <year>1989</year>
            <month>Aug</month>
            <day>26</day>
            <volume>299</volume>
            <issue>6698</issue>
            <fpage>541</fpage>
            <page-range>541-5</page-range>
            <pub-id pub-id-type="pmid">2507063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dogra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Paspulati</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>First trimester bleeding evaluation.</article-title>
            <source>Ultrasound Q</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>69</fpage>
            <page-range>69-85; quiz 149-50, 153-4</page-range>
            <pub-id pub-id-type="pmid">15905817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giacomello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Magliocchetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Loyola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giovarruscio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Serum beta hCG levels and transvaginal echography in the early phases of pregnancy].</article-title>
            <source>Minerva Ginecol</source>
            <year>1993</year>
            <season>Jul-Aug</season>
            <volume>45</volume>
            <issue>7-8</issue>
            <fpage>333</fpage>
            <page-range>333-7</page-range>
            <pub-id pub-id-type="pmid">8414139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doubilet</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Blaivas</surname>
                <given-names>M</given-names>
              </name>
              <collab>Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy</collab>
              <name>
                <surname>Barnhart</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Benacerraf</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Filly</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Pretorius</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Timor-Tritsch</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic criteria for nonviable pregnancy early in the first trimester.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Oct</month>
            <day>10</day>
            <volume>369</volume>
            <issue>15</issue>
            <fpage>1443</fpage>
            <page-range>1443-51</page-range>
            <pub-id pub-id-type="pmid">24106937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <article-title>The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>May</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>1258</fpage>
            <page-range>1258-1267</page-range>
            <pub-id pub-id-type="pmid">25932865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luise</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jermy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Outcome of expectant management of spontaneous first trimester miscarriage: observational study.</article-title>
            <source>BMJ</source>
            <year>2002</year>
            <month>Apr</month>
            <day>13</day>
            <volume>324</volume>
            <issue>7342</issue>
            <fpage>873</fpage>
            <page-range>873-5</page-range>
            <pub-id pub-id-type="pmid">11950733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>MM</given-names>
              </name>
              <collab>National Institute of Child Health Human Development (NICHD) Management of Early Pregnancy Failure Trial</collab>
            </person-group>
            <article-title>A comparison of medical management with misoprostol and surgical management for early pregnancy failure.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Aug</month>
            <day>25</day>
            <volume>353</volume>
            <issue>8</issue>
            <fpage>761</fpage>
            <page-range>761-9</page-range>
            <pub-id pub-id-type="pmid">16120856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Empson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lassere</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2005</year>
            <month>Apr</month>
            <day>18</day>
            <volume>2005</volume>
            <issue>2</issue>
            <fpage>CD002859</fpage>
            <pub-id pub-id-type="pmid">15846641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Jong</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kaandorp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Nisio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goddijn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <day>04</day>
            <volume>2014</volume>
            <issue>7</issue>
            <fpage>CD004734</fpage>
            <pub-id pub-id-type="pmid">24995856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Curtis</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Tepper</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Jatlaoui</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Berry-Bibee</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Zapata</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Pagano</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Whiteman</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2016</year>
            <month>Jul</month>
            <day>29</day>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>1</fpage>
            <page-range>1-103</page-range>
            <pub-id pub-id-type="pmid">27467196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharp</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Lemieux</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Currigan</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Executive Summary of the reVITALize Initiative: Standardizing Gynecologic Data Definitions.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>603</fpage>
            <page-range>603-607</page-range>
            <pub-id pub-id-type="pmid">28277367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25187.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quenby</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gallos</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Dhillon-Smith</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Podesek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brosens</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Brewin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramhorst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Al-Memar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>MacIntyre</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Sugiura-Ogasawara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Odendaal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Devall</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.</article-title>
            <source>Lancet</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>397</volume>
            <issue>10285</issue>
            <fpage>1658</fpage>
            <page-range>1658-1667</page-range>
            <pub-id pub-id-type="pmid">33915094</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
